Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$74.10
-0.1%
$63.90
$47.31
$87.32
$3.37B0.561.05 million shs887,719 shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$140.37
$129.95
$107.00
$160.29
$3.51B0.77285,557 shs506,719 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$67.22
$65.45
$59.74
$96.74
$4.01B0.54740,948 shs1.18 million shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$29.12
$28.47
$15.59
$35.87
$1.45B1.23662,894 shs818,048 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%-4.86%+24.66%+26.49%+5.87%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.00%-1.29%+8.55%+11.97%+9.17%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.00%+1.04%+4.23%+0.76%-27.68%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.00%+2.64%-11.89%+66.21%+72.82%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$74.10
-0.1%
$63.90
$47.31
$87.32
$3.37B0.561.05 million shs887,719 shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$140.37
$129.95
$107.00
$160.29
$3.51B0.77285,557 shs506,719 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$67.22
$65.45
$59.74
$96.74
$4.01B0.54740,948 shs1.18 million shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$29.12
$28.47
$15.59
$35.87
$1.45B1.23662,894 shs818,048 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%-4.86%+24.66%+26.49%+5.87%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.00%-1.29%+8.55%+11.97%+9.17%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.00%+1.04%+4.23%+0.76%-27.68%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.00%+2.64%-11.89%+66.21%+72.82%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Haemonetics Corporation stock logo
HAE
Haemonetics
2.64
Moderate Buy$78.335.71% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
2.88
Moderate Buy$168.4019.97% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
2.64
Moderate Buy$92.8038.05% Upside
STAAR Surgical Company stock logo
STAA
STAAR Surgical
2.09
Hold$27.81-4.49% Downside

Current Analyst Ratings Breakdown

Latest STAA, MMSI, ICUI, and HAE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/17/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Reiterated RatingBuy$84.00
6/15/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Boost Price TargetOutperform$70.00 ➝ $85.00
6/15/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
DowngradeMarket Perform
6/15/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Initiated CoverageBuy$170.00
6/15/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Initiated CoverageBuy$170.00
5/29/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Reiterated RatingOutperform$40.00
5/28/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Boost Price TargetNeutral$64.00 ➝ $70.00
5/27/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
UpgradeHoldBuy$165.00
5/22/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
UpgradeNeutralBuy$72.00 ➝ $80.00
5/21/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
DowngradeHold (C-)Sell (D+)
5/15/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Boost Price TargetEqual Weight$16.00 ➝ $25.00
(Data available from 6/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.33B2.52$7.57 per share9.79$17.14 per share4.32
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.23B1.57$14.58 per share9.63$86.03 per share1.63
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.54B2.60$5.88 per share11.43$26.72 per share2.52
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$239.44M6.06N/AN/A$6.92 per share4.21
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Haemonetics Corporation stock logo
HAE
Haemonetics
$97.31M$2.0236.6812.911.497.29%27.30%9.59%8/6/2026 (Estimated)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$730K$1.8575.8818.021.962.15%7.50%3.91%8/6/2026 (Estimated)
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$128.49M$2.3129.1017.062.099.03%13.54%7.94%7/29/2026 (Estimated)
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-$80.45M-$0.43N/A97.07N/A-7.24%3.31%2.55%8/12/2026 (Estimated)

Latest STAA, MMSI, ICUI, and HAE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$0.0542$0.10+$0.0458$0.10$78.72 million$93.52 million
5/7/2026Q4 2026
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.28$1.29+$0.01-$0.44$336.83 million$346.35 million
5/7/2026Q1 2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$1.78$1.97+$0.19$1.20$520.65 million$525.77 million
4/30/2026Q1 2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.84$0.94+$0.10$0.68$377.59 million$381.88 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Haemonetics Corporation stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Haemonetics Corporation stock logo
HAE
Haemonetics
1.53
2.95
1.87
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.60
2.34
1.17
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.45
5.08
3.46
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.09
5.12
4.31

Institutional Ownership

CompanyInstitutional Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
99.67%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
2.07%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
2.10%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.70%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
39.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Haemonetics Corporation stock logo
HAE
Haemonetics
3,00945.45 million44.51 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
13,00024.99 million24.47 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
7,50059.66 million59.24 millionOptionable
STAAR Surgical Company stock logo
STAA
STAAR Surgical
1,21149.79 million29.92 millionOptionable

Recent News About These Companies

Is STAAR Surgical Regaining Market Momentum?
Staar Surgical Jumps 15% After Hours
Staar Surgical: Q1 Earnings Snapshot
Staar Surgical Shares Rise After Swing to 1Q Profit
STAAR Surgical (STAA) Q1 2026 Earnings Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Haemonetics stock logo

Haemonetics NYSE:HAE

$74.10 -0.07 (-0.09%)
Closing price 06/18/2026 03:59 PM Eastern
Extended Trading
$74.17 +0.07 (+0.09%)
As of 06/18/2026 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

ICU Medical stock logo

ICU Medical NASDAQ:ICUI

$140.37 0.00 (0.00%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$140.44 +0.07 (+0.05%)
As of 06/18/2026 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Merit Medical Systems stock logo

Merit Medical Systems NASDAQ:MMSI

$67.22 0.00 (0.00%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$67.50 +0.28 (+0.41%)
As of 06/18/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

STAAR Surgical stock logo

STAAR Surgical NASDAQ:STAA

$29.12 0.00 (0.00%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$29.12 0.00 (0.00%)
As of 06/18/2026 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.